Skip to main content
Premium Trial:

Request an Annual Quote

Soren Tulstrup, Jim Meade, Victor Ambros

Premium
Santaris Pharma said this week that Soren Tulstrup has been named as the company’s new president and CEO, effective July 1.
 
He will replace current President and CEO Keith McCullagh, who is retiring but will remain on the company’s board.
 
Tulstrup previously served as vice president of global health at Merck. Before that, he served as managing director of Merck subsidiary Merck, Sharp, & Dohme Ireland. He has also held various positions at Sandoz and Abbott Laboratories.
 
He has an MS in economics from Copenhagen Business School and an MBA from the JL Kellogg Graduate School of Management at Northwestern University.
 

 
Lentiviral vector firm Lentigen has named Jim Meade as vice president of corporate development.
 
Meade will be responsible for managing partnerships, stakeholder relations, product and intellectual property portfolios, contract negotiations, and other key aspects of corporate development, Lentigen said.
 
He previously served as vice president of business development at Avalon Pharmaceuticals. He holds a PhD in molecular biology from the University of Texas.
 

 
Victor Ambros, a researcher at the University of Massachusetts Medical School and microRNA pioneer, has joined RXi Pharmaceuticals’ scientific advisory board.
 
In 1993, Ambros first published the discovery of the first miRNA and reported how the small RNA regulated gene translation in C. elegans “via an antisense RNA-RNA interaction.”

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.